RAPTOR RESOURCES LIMITED - Announcements

0.00%

20.5¢

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

ResApp Health Limited is an Australia-based digital health company engaged in developing... ResApp Health Limited is an Australia-based digital health company engaged in developing smartphone applications for the diagnosis and management of respiratory disease. The Company provides point of care diagnostic solutions for telehealth that are integrated into existing platforms. The Company is focused on developing apps to provide instant clinical diagnostic tests and management tools directly to consumers and healthcare providers. The Company’s machine learning algorithms use sound to diagnose and measure the severity of respiratory conditions without the need for additional accessories or hardware. Its products include ResAppDx, a smartphone-based acute respiratory disease diagnostic test for use in telehealth, emergency department and primary care settings; and SleepCheck, a smartphone application which allows consumers to self-assess their risk of sleep apnoea. Its obstructive sleep aponia screening test uses overnight breathing and snoring sounds recorded on a smartphone.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

RAP	Scheme of Arrangement has been Implemented	PRICE SENSITIVE	26/09/22	55.41KB	Share
RAP	Suspension from Official Quotation	PRICE SENSITIVE	15/09/22	591.98KB	Share
RAP	Scheme of Arrangement becomes effective	PRICE SENSITIVE	15/09/22	130.98KB	Share
RAP	Scheme of Arrangement - Court Approval	PRICE SENSITIVE	14/09/22	89.15KB	Share
RAP	Results of Scheme Meeting	PRICE SENSITIVE	07/09/22	185.86KB	Share
RAP	Scheme Meeting - Chairman's Address & Presentation	PRICE SENSITIVE	07/09/22	2.89MB	Share
RAP	Appendix 4E and Annual Report	PRICE SENSITIVE	30/08/22	2.18MB	Share
RAP	Second Supplementary Scheme Booklet	PRICE SENSITIVE	25/08/22	918.11KB	Share
RAP	Adjournment of Scheme Meeting to a date to be determined	PRICE SENSITIVE	19/08/22	66.64KB	Share
RAP	Best and Final Confirmation and Bridging Loan	PRICE SENSITIVE	16/08/22	489.09KB	Share
RAP	Pfizer raises scheme consideration to A$0.208 per share	PRICE SENSITIVE	05/08/22	473.41KB	Share
RAP	Entry into amended and restated Scheme Implementation Deed	PRICE SENSITIVE	03/08/22	975.99KB	Share
RAP	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	27/07/22	1.2MB	Share
RAP	Scheme Update - ACCC condition precedent satisfied	PRICE SENSITIVE	18/07/22	95.44KB	Share
RAP	Scheme Booklet registered with ASIC	PRICE SENSITIVE	18/07/22	4.14MB	Share
RAP	Results of First Court Hearing	PRICE SENSITIVE	15/07/22	131.07KB	Share
RAP	Medgate extends licence agreement and plans to expand use	PRICE SENSITIVE	07/07/22	107.19KB	Share
RAP	ResApp receives FDA 510(k) clearance for SleepCheckRx	PRICE SENSITIVE	06/07/22	106.06KB	Share
RAP	Results from Data Confirmation Study	PRICE SENSITIVE	21/06/22	112.24KB	Share
RAP	Trading Halt	PRICE SENSITIVE	20/06/22	675.51KB	Share
RAP	Reinstatement to Official Quotation	PRICE SENSITIVE	14/06/22	410.87KB	Share
RAP	Increased Scheme Consideration from Pfizer	PRICE SENSITIVE	14/06/22	833.75KB	Share
RAP	Suspension from Official Quotation	PRICE SENSITIVE	02/06/22	668.62KB	Share
RAP	Trading Halt	PRICE SENSITIVE	31/05/22	678.4KB	Share
RAP	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	26/04/22	324.36KB	Share
RAP	Proposed Acquisition of ResApp Health by Pfizer	PRICE SENSITIVE	11/04/22	850.05KB	Share
RAP	Dartford and Gravesham NHS Trust to pilot ResAppDx	PRICE SENSITIVE	01/04/22	109.29KB	Share
RAP	Reinstatement to Official Quotation	PRICE SENSITIVE	22/03/22	406.85KB	Share
RAP	ResApp announces positive results of COVID-19 screening test	PRICE SENSITIVE	22/03/22	142.1KB	Share
RAP	Suspension from Official Quotation	PRICE SENSITIVE	21/03/22	548.98KB	Share
RAP	Trading Halt	PRICE SENSITIVE	17/03/22	241.41KB	Share
RAP	Half Yearly Report and Accounts	PRICE SENSITIVE	25/02/22	718.08KB	Share
RAP	Health Teams to launch ResAppDx on aged care platform	PRICE SENSITIVE	14/02/22	109KB	Share
RAP	Cough analysis patent granted in China	PRICE SENSITIVE	01/02/22	97.76KB	Share
RAP	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	28/01/22	1.2MB	Share
RAP	ResAppDx goes live with Doctors on Demand in Australia	PRICE SENSITIVE	24/01/22	99.78KB	Share
RAP	LOI signed with Homify to launch ResAppDx in the Philippines	PRICE SENSITIVE	20/01/22	105.46KB	Share
RAP	US COVID-19 study completes recruitment	PRICE SENSITIVE	10/01/22	84.23KB	Share
RAP	ResAppDx goes live with Alodokter in Indonesia	PRICE SENSITIVE	07/01/22	98.73KB	Share
RAP	Distribution agreement with Sanrai International	PRICE SENSITIVE	22/12/21	113.66KB	Share
RAP	ResApp receives $818,826 in R&D tax incentive refund	PRICE SENSITIVE	20/12/21	96.72KB	Share
RAP	ResApp receives regulatory approvals for cough counter	PRICE SENSITIVE	29/11/21	105.1KB	Share
RAP	ResApp completes COVID-19 study recruitment in India	PRICE SENSITIVE	23/11/21	106.18KB	Share
RAP	ResApp secures contract with global pharmaceutical company	PRICE SENSITIVE	18/11/21	112.79KB	Share
RAP	IRB approval for US COVID-19 study modification	PRICE SENSITIVE	15/11/21	112.12KB	Share
RAP	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	28/10/21	311.74KB	Share
RAP	COVID-19 Clinical Studies Update	PRICE SENSITIVE	26/10/21	109.26KB	Share
RAP	ResApp announces FDA 510(k) submission for SleepCheckRx	PRICE SENSITIVE	11/10/21	120.85KB	Share
RAP	ResApp receives Advanced and Overseas R&D Finding	PRICE SENSITIVE	14/09/21	103.8KB	Share
RAP	Appendix 4E and Annual Report	PRICE SENSITIVE	27/08/21	6.2MB	Share
RAP	Alodokter to launch ResAppDx in Indonesia	PRICE SENSITIVE	04/08/21	113.3KB	Share
RAP	Medgate enters licence agreement with ResApp Health	PRICE SENSITIVE	04/08/21	113.2KB	Share
RAP	Trading Halt	PRICE SENSITIVE	02/08/21	226.82KB	Share
RAP	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	30/07/21	323.96KB	Share
RAP	Commercial agreement with Doctors on Demand in Australia	PRICE SENSITIVE	05/07/21	121.05KB	Share
RAP	Agreement with Ilara Health to sell ResAppDx in Kenya	PRICE SENSITIVE	04/05/21	118.61KB	Share
RAP	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	30/04/21	322.27KB	Share
RAP	ResApp secures firm commitments to raise $5.5 million	PRICE SENSITIVE	12/04/21	125.67KB	Share
RAP	Trading Halt	PRICE SENSITIVE	08/04/21	566.64KB	Share
RAP	S&P DJI Announces March 2021 Quarterly Rebalance	PRICE SENSITIVE	12/03/21	183.24KB	Share
RAP	ResApp grants SDK licence to AstraZeneca for asthma program	PRICE SENSITIVE	12/03/21	117.37KB	Share
RAP	Clinical study to develop COVID-19 screening test	PRICE SENSITIVE	11/03/21	121.12KB	Share
RAP	Medgate commences European ResAppDx trial	PRICE SENSITIVE	04/03/21	104.25KB	Share
RAP	CE Mark achieved for wearable device	PRICE SENSITIVE	02/03/21	2.35MB	Share
RAP	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	24/02/21	1.89MB	Share
RAP	Pre-Submission package lodged with the US FDA	PRICE SENSITIVE	10/02/21	99.76KB	Share
RAP	ResApp receives $801,738 R&D tax incentive refund and grant	PRICE SENSITIVE	04/02/21	88.81KB	Share
RAP	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	29/01/21	332.05KB	Share
RAP	SleepCheck Launched on Select Android Devices	PRICE SENSITIVE	29/12/20	108.43KB	Share
RAP	S&P DJI Announces December 2020 Quarterly Rebalance	PRICE SENSITIVE	11/12/20	118.95KB	Share
RAP	Medgate to pilot ResAppDx for telehealth across Europe	PRICE SENSITIVE	09/11/20	112.99KB	Share
RAP	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	30/10/20	334.04KB	Share
RAP	ResAppDx launched on select Android devices	PRICE SENSITIVE	28/10/20	110.79KB	Share
RAP	AstraZeneca to use new ResApp software in study - Revised	PRICE SENSITIVE	22/10/20	116.6KB	Share
RAP	Pause in Trading	PRICE SENSITIVE	22/10/20	114.77KB	Share
RAP	AstraZeneca to use new ResApp software in clinical study	PRICE SENSITIVE	22/10/20	116.53KB	Share
RAP	Partners with largest Australian consumer healthcare network	PRICE SENSITIVE	21/10/20	137.87KB	Share
RAP	Appendix 4E and Annual Report	PRICE SENSITIVE	31/08/20	1.3MB	Share
RAP	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	29/07/20	297.01KB	Share
RAP	Coviu and ResApp Health Sign Service Agreement	PRICE SENSITIVE	01/07/20	191.9KB	Share
RAP	SleepCheck App for iPhone Now Available on the App Store	PRICE SENSITIVE	29/06/20	757.94KB	Share
RAP	ResApp Signs MOU to Develop Respiratory App for Consumers	PRICE SENSITIVE	18/06/20	96.29KB	Share
RAP	Phenix and ResApp Sign Software Licensing Agreement	PRICE SENSITIVE	16/06/20	119.7KB	Share
RAP	S&P DJI Announces June 2020 Quarterly Rebalance	PRICE SENSITIVE	12/06/20	223.16KB	Share
RAP	ResAppDx-EU in Use at COVID-19 Respiratory Clinic	PRICE SENSITIVE	11/05/20	102.33KB	Share
RAP	ResApp Receives Final Design Files for Hardware Devices	PRICE SENSITIVE	06/05/20	99.11KB	Share
RAP	Quarterly Update and Appendix 4C	PRICE SENSITIVE	30/04/20	280.3KB	Share
RAP	ResApp Announces SleepCheck, a Sleep Apnoea Screening App	PRICE SENSITIVE	01/04/20	949.54KB	Share
RAP	Coviu and ResApp Complete Initial ResAppDx-EU Integration	PRICE SENSITIVE	30/03/20	191.25KB	Share
RAP	ResAppDx-EU to be Deployed on Phenix Health Telehealth App	PRICE SENSITIVE	24/03/20	118.88KB	Share
RAP	Update on US FDA De Novo Classification Request	PRICE SENSITIVE	11/03/20	98.82KB	Share
RAP	Direct-to-Consumer Product Update	PRICE SENSITIVE	11/03/20	94.71KB	Share
RAP	Trading Halt	PRICE SENSITIVE	09/03/20	205.62KB	Share
RAP	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	28/02/20	1.8MB	Share
RAP	ResApp Completes $5 Million Capital Raising	PRICE SENSITIVE	21/02/20	77.25KB	Share
RAP	TGA Approval for Adult Respiratory Disease Diagnosis	PRICE SENSITIVE	20/02/20	78.83KB	Share
RAP	Trading Halt	PRICE SENSITIVE	19/02/20	203.9KB	Share
RAP	Functional Testing of Handheld and Wearable Devices Complete	PRICE SENSITIVE	18/02/20	80.02KB	Share
RAP	Quarterly Update and Appendix 4C	PRICE SENSITIVE	31/01/20	288.56KB	Share
RAP	Clinical Study of COPD Screening in Indigenous Australians	PRICE SENSITIVE	19/12/19	82.79KB	Share

RAP Scheme of Arrangement has been Implemented
26/09/22	PRICE SENSITIVE	55.41KB	Share
RAP Suspension from Official Quotation
15/09/22	PRICE SENSITIVE	591.98KB	Share
RAP Scheme of Arrangement becomes effective
15/09/22	PRICE SENSITIVE	130.98KB	Share
RAP Scheme of Arrangement - Court Approval
14/09/22	PRICE SENSITIVE	89.15KB	Share
RAP Results of Scheme Meeting
07/09/22	PRICE SENSITIVE	185.86KB	Share
RAP Scheme Meeting - Chairman's Address & Presentation
07/09/22	PRICE SENSITIVE	2.89MB	Share
RAP Appendix 4E and Annual Report
30/08/22	PRICE SENSITIVE	2.18MB	Share
RAP Second Supplementary Scheme Booklet
25/08/22	PRICE SENSITIVE	918.11KB	Share
RAP Adjournment of Scheme Meeting to a date to be determined
19/08/22	PRICE SENSITIVE	66.64KB	Share
RAP Best and Final Confirmation and Bridging Loan
16/08/22	PRICE SENSITIVE	489.09KB	Share
RAP Pfizer raises scheme consideration to A$0.208 per share
05/08/22	PRICE SENSITIVE	473.41KB	Share
RAP Entry into amended and restated Scheme Implementation Deed
03/08/22	PRICE SENSITIVE	975.99KB	Share
RAP Quarterly Activities Report and Appendix 4C
27/07/22	PRICE SENSITIVE	1.2MB	Share
RAP Scheme Update - ACCC condition precedent satisfied
18/07/22	PRICE SENSITIVE	95.44KB	Share
RAP Scheme Booklet registered with ASIC
18/07/22	PRICE SENSITIVE	4.14MB	Share
RAP Results of First Court Hearing
15/07/22	PRICE SENSITIVE	131.07KB	Share
RAP Medgate extends licence agreement and plans to expand use
07/07/22	PRICE SENSITIVE	107.19KB	Share
RAP ResApp receives FDA 510(k) clearance for SleepCheckRx
06/07/22	PRICE SENSITIVE	106.06KB	Share
RAP Results from Data Confirmation Study
21/06/22	PRICE SENSITIVE	112.24KB	Share
RAP Trading Halt
20/06/22	PRICE SENSITIVE	675.51KB	Share
RAP Reinstatement to Official Quotation
14/06/22	PRICE SENSITIVE	410.87KB	Share
RAP Increased Scheme Consideration from Pfizer
14/06/22	PRICE SENSITIVE	833.75KB	Share
RAP Suspension from Official Quotation
02/06/22	PRICE SENSITIVE	668.62KB	Share
RAP Trading Halt
31/05/22	PRICE SENSITIVE	678.4KB	Share
RAP Quarterly Activities Report and Appendix 4C
26/04/22	PRICE SENSITIVE	324.36KB	Share
RAP Proposed Acquisition of ResApp Health by Pfizer
11/04/22	PRICE SENSITIVE	850.05KB	Share
RAP Dartford and Gravesham NHS Trust to pilot ResAppDx
01/04/22	PRICE SENSITIVE	109.29KB	Share
RAP Reinstatement to Official Quotation
22/03/22	PRICE SENSITIVE	406.85KB	Share
RAP ResApp announces positive results of COVID-19 screening test
22/03/22	PRICE SENSITIVE	142.1KB	Share
RAP Suspension from Official Quotation
21/03/22	PRICE SENSITIVE	548.98KB	Share
RAP Trading Halt
17/03/22	PRICE SENSITIVE	241.41KB	Share
RAP Half Yearly Report and Accounts
25/02/22	PRICE SENSITIVE	718.08KB	Share
RAP Health Teams to launch ResAppDx on aged care platform
14/02/22	PRICE SENSITIVE	109KB	Share
RAP Cough analysis patent granted in China
01/02/22	PRICE SENSITIVE	97.76KB	Share
RAP Quarterly Activities Report and Appendix 4C
28/01/22	PRICE SENSITIVE	1.2MB	Share
RAP ResAppDx goes live with Doctors on Demand in Australia
24/01/22	PRICE SENSITIVE	99.78KB	Share
RAP LOI signed with Homify to launch ResAppDx in the Philippines
20/01/22	PRICE SENSITIVE	105.46KB	Share
RAP US COVID-19 study completes recruitment
10/01/22	PRICE SENSITIVE	84.23KB	Share
RAP ResAppDx goes live with Alodokter in Indonesia
07/01/22	PRICE SENSITIVE	98.73KB	Share
RAP Distribution agreement with Sanrai International
22/12/21	PRICE SENSITIVE	113.66KB	Share
RAP ResApp receives $818,826 in R&D tax incentive refund
20/12/21	PRICE SENSITIVE	96.72KB	Share
RAP ResApp receives regulatory approvals for cough counter
29/11/21	PRICE SENSITIVE	105.1KB	Share
RAP ResApp completes COVID-19 study recruitment in India
23/11/21	PRICE SENSITIVE	106.18KB	Share
RAP ResApp secures contract with global pharmaceutical company
18/11/21	PRICE SENSITIVE	112.79KB	Share
RAP IRB approval for US COVID-19 study modification
15/11/21	PRICE SENSITIVE	112.12KB	Share
RAP Quarterly Activities Report and Appendix 4C
28/10/21	PRICE SENSITIVE	311.74KB	Share
RAP COVID-19 Clinical Studies Update
26/10/21	PRICE SENSITIVE	109.26KB	Share
RAP ResApp announces FDA 510(k) submission for SleepCheckRx
11/10/21	PRICE SENSITIVE	120.85KB	Share
RAP ResApp receives Advanced and Overseas R&D Finding
14/09/21	PRICE SENSITIVE	103.8KB	Share
RAP Appendix 4E and Annual Report
27/08/21	PRICE SENSITIVE	6.2MB	Share
RAP Alodokter to launch ResAppDx in Indonesia
04/08/21	PRICE SENSITIVE	113.3KB	Share
RAP Medgate enters licence agreement with ResApp Health
04/08/21	PRICE SENSITIVE	113.2KB	Share
RAP Trading Halt
02/08/21	PRICE SENSITIVE	226.82KB	Share
RAP Quarterly Activities Report and Appendix 4C
30/07/21	PRICE SENSITIVE	323.96KB	Share
RAP Commercial agreement with Doctors on Demand in Australia
05/07/21	PRICE SENSITIVE	121.05KB	Share
RAP Agreement with Ilara Health to sell ResAppDx in Kenya
04/05/21	PRICE SENSITIVE	118.61KB	Share
RAP Quarterly Activities Report and Appendix 4C
30/04/21	PRICE SENSITIVE	322.27KB	Share
RAP ResApp secures firm commitments to raise $5.5 million
12/04/21	PRICE SENSITIVE	125.67KB	Share
RAP Trading Halt
08/04/21	PRICE SENSITIVE	566.64KB	Share
RAP S&P DJI Announces March 2021 Quarterly Rebalance
12/03/21	PRICE SENSITIVE	183.24KB	Share
RAP ResApp grants SDK licence to AstraZeneca for asthma program
12/03/21	PRICE SENSITIVE	117.37KB	Share
RAP Clinical study to develop COVID-19 screening test
11/03/21	PRICE SENSITIVE	121.12KB	Share
RAP Medgate commences European ResAppDx trial
04/03/21	PRICE SENSITIVE	104.25KB	Share
RAP CE Mark achieved for wearable device
02/03/21	PRICE SENSITIVE	2.35MB	Share
RAP Appendix 4D and Half Year Financial Report
24/02/21	PRICE SENSITIVE	1.89MB	Share
RAP Pre-Submission package lodged with the US FDA
10/02/21	PRICE SENSITIVE	99.76KB	Share
RAP ResApp receives $801,738 R&D tax incentive refund and grant
04/02/21	PRICE SENSITIVE	88.81KB	Share
RAP Quarterly Activities Report and Appendix 4C
29/01/21	PRICE SENSITIVE	332.05KB	Share
RAP SleepCheck Launched on Select Android Devices
29/12/20	PRICE SENSITIVE	108.43KB	Share
RAP S&P DJI Announces December 2020 Quarterly Rebalance
11/12/20	PRICE SENSITIVE	118.95KB	Share
RAP Medgate to pilot ResAppDx for telehealth across Europe
09/11/20	PRICE SENSITIVE	112.99KB	Share
RAP Quarterly Activities Report and Appendix 4C
30/10/20	PRICE SENSITIVE	334.04KB	Share
RAP ResAppDx launched on select Android devices
28/10/20	PRICE SENSITIVE	110.79KB	Share
RAP AstraZeneca to use new ResApp software in study - Revised
22/10/20	PRICE SENSITIVE	116.6KB	Share
RAP Pause in Trading
22/10/20	PRICE SENSITIVE	114.77KB	Share
RAP AstraZeneca to use new ResApp software in clinical study
22/10/20	PRICE SENSITIVE	116.53KB	Share
RAP Partners with largest Australian consumer healthcare network
21/10/20	PRICE SENSITIVE	137.87KB	Share
RAP Appendix 4E and Annual Report
31/08/20	PRICE SENSITIVE	1.3MB	Share
RAP Quarterly Activities Report and Appendix 4C
29/07/20	PRICE SENSITIVE	297.01KB	Share
RAP Coviu and ResApp Health Sign Service Agreement
01/07/20	PRICE SENSITIVE	191.9KB	Share
RAP SleepCheck App for iPhone Now Available on the App Store
29/06/20	PRICE SENSITIVE	757.94KB	Share
RAP ResApp Signs MOU to Develop Respiratory App for Consumers
18/06/20	PRICE SENSITIVE	96.29KB	Share
RAP Phenix and ResApp Sign Software Licensing Agreement
16/06/20	PRICE SENSITIVE	119.7KB	Share
RAP S&P DJI Announces June 2020 Quarterly Rebalance
12/06/20	PRICE SENSITIVE	223.16KB	Share
RAP ResAppDx-EU in Use at COVID-19 Respiratory Clinic
11/05/20	PRICE SENSITIVE	102.33KB	Share
RAP ResApp Receives Final Design Files for Hardware Devices
06/05/20	PRICE SENSITIVE	99.11KB	Share
RAP Quarterly Update and Appendix 4C
30/04/20	PRICE SENSITIVE	280.3KB	Share
RAP ResApp Announces SleepCheck, a Sleep Apnoea Screening App
01/04/20	PRICE SENSITIVE	949.54KB	Share
RAP Coviu and ResApp Complete Initial ResAppDx-EU Integration
30/03/20	PRICE SENSITIVE	191.25KB	Share
RAP ResAppDx-EU to be Deployed on Phenix Health Telehealth App
24/03/20	PRICE SENSITIVE	118.88KB	Share
RAP Update on US FDA De Novo Classification Request
11/03/20	PRICE SENSITIVE	98.82KB	Share
RAP Direct-to-Consumer Product Update
11/03/20	PRICE SENSITIVE	94.71KB	Share
RAP Trading Halt
09/03/20	PRICE SENSITIVE	205.62KB	Share
RAP Appendix 4D and Half Year Financial Report
28/02/20	PRICE SENSITIVE	1.8MB	Share
RAP ResApp Completes $5 Million Capital Raising
21/02/20	PRICE SENSITIVE	77.25KB	Share
RAP TGA Approval for Adult Respiratory Disease Diagnosis
20/02/20	PRICE SENSITIVE	78.83KB	Share
RAP Trading Halt
19/02/20	PRICE SENSITIVE	203.9KB	Share
RAP Functional Testing of Handheld and Wearable Devices Complete
18/02/20	PRICE SENSITIVE	80.02KB	Share
RAP Quarterly Update and Appendix 4C
31/01/20	PRICE SENSITIVE	288.56KB	Share
RAP Clinical Study of COPD Screening in Indigenous Australians
19/12/19	PRICE SENSITIVE	82.79KB	Share

REFRESH

1 2

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

RAPTOR RESOURCES LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Top Stories

Corporate Spotlight
Not Yet Available